{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:36:11Z","timestamp":1772814971236,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T00:00:00Z","timestamp":1280188800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00702-010-0443-2","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T05:30:56Z","timestamp":1280122256000},"page":"1027-1032","source":"Crossref","is-referenced-by-count":15,"title":["Modulatory role of the endogenous nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), in morphine tolerance and dependence in mice"],"prefix":"10.1007","volume":"117","author":[{"given":"Ozgur","family":"Gunduz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cetin Hakan","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Ulugol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,27]]},"reference":[{"key":"443_CR1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","volume":"88","author":"F Abbasi","year":"2001","unstructured":"Abbasi F, Asagmi T, Cooke JP, Lamendola C, Mclaughlin T, Reaven GM, Stuehlinger M, Tsao PS (2001) Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol 88:1201\u20131203","journal-title":"Am J Cardiol"},{"key":"443_CR2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF03347423","volume":"30","author":"E Arikan","year":"2007","unstructured":"Arikan E, Karadag CH, Guldiken S (2007) Asymmetric dimethylarginine levels in thyroid diseases. J Endocrinol Invest 30:186\u2013191","journal-title":"J Endocrinol Invest"},{"key":"443_CR3","first-page":"A1234","volume":"20","author":"MJ Barjavel","year":"1994","unstructured":"Barjavel MJ, Bhargava HN (1994) Effect of morphine tolerance and abstinence on nitric oxide synthase activity in brain regions and spinal cord of the mouse. Soc Neurosci Abstr 20:A1234","journal-title":"Soc Neurosci Abstr"},{"key":"443_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0031-6997(25)06808-5","volume":"46","author":"HN Bhargava","year":"1994","unstructured":"Bhargava HN (1994) Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self administrative behavior. Pharmacol Rev 46:293\u2013324","journal-title":"Pharmacol Rev"},{"key":"443_CR5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000139371","volume":"52","author":"HN Bhargava","year":"1998","unstructured":"Bhargava HN (1998) Nitric oxide synthase inhibition blocks tolerance to the analgesic action of k-opiate receptor agonist in the rat. Pharmacology 52:86\u201391","journal-title":"Pharmacology"},{"key":"443_CR6","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000139371","volume":"52","author":"HN Bhargava","year":"1996","unstructured":"Bhargava HN, Thorat SN (1996) Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome. Pharmacology 52:86\u201391","journal-title":"Pharmacology"},{"key":"443_CR7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0022-3565(24)36638-8","volume":"281","author":"HN Bhargava","year":"1997","unstructured":"Bhargava HN, Bian JT, Kumar S (1997a) Mechanism of attenuation of morphine by chronic treatment with l-arginine. J Pharmacol Exp Ther 281:707\u2013712","journal-title":"J Pharmacol Exp Ther"},{"key":"443_CR8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0196-9781(97)00021-1","volume":"18","author":"HN Bhargava","year":"1997","unstructured":"Bhargava HN, Cao YJ, Zhao GM (1997b) Effect of 7-nitroindazole on tolerance to morphine, U-50, 488H and [d-Pen2, d-Pen5] enkephalin in mice. Peptides 18:797\u2013800","journal-title":"Peptides"},{"key":"443_CR9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pharmthera.2007.03.002","volume":"114","author":"SM Bode-B\u00f6ger","year":"2007","unstructured":"Bode-B\u00f6ger SM, Scalera F, Ignarro LJ (2007) The l-arginine paradox: importance of the l-arginine\/asymmetrical dimethylarginine ratio. Pharmacol Therapeut 114:295\u2013306","journal-title":"Pharmacol Therapeut"},{"key":"443_CR10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1476-5381.1996.tb15280.x","volume":"117","author":"YM Dambisya","year":"1996","unstructured":"Dambisya YM, Lee TL (1996) Role of nitric oxide in the induction and expression of morphine tolerance and dependence in mice. Br J Pharmacol 117:914\u2013918","journal-title":"Br J Pharmacol"},{"key":"443_CR11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0166-2236(91)90022-M","volume":"14","author":"J Garthweite","year":"1991","unstructured":"Garthweite J (1991) Glutamate, nitric oxide and cell\u2013cell signaling in the nervous system. Trends Neurosci 14:60\u201367","journal-title":"Trends Neurosci"},{"key":"443_CR12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bcp.2003.08.046","volume":"67","author":"EL Heinzen","year":"2004","unstructured":"Heinzen EL, Pollack GM (2004a) The development of morphine antinociceptive tolerance in nitric oxide synthase-deficient mice. Biochem Pharmacol 67:735\u2013741","journal-title":"Biochem Pharmacol"},{"key":"443_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.brainres.2004.07.015","volume":"1023","author":"EL Heinzen","year":"2004","unstructured":"Heinzen EL, Pollack GM (2004b) Pharmacodynamics of morphine-induced neuronal nitric oxide production and antinociceptive tolerance development. Brain Res 1023:175\u2013184","journal-title":"Brain Res"},{"key":"443_CR14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bcp.2004.11.004","volume":"69","author":"EL Heinzen","year":"2005","unstructured":"Heinzen EL, Booth RG, Pollack GM (2005) Neuronal nitric oxide modulates morphine antinociceptive tolerance by enhancing constitutive activity of the \u03bc-opioid receptor. Biochem Pharmacol 69:679\u2013688","journal-title":"Biochem Pharmacol"},{"key":"443_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.niox.2007.05.005","volume":"17","author":"A Kielstein","year":"2007","unstructured":"Kielstein A, Tsikas D, Galloway GP, Mendelson JE (2007) Asymmetric dimethylarginine (ADMA)\u2014a modulator of nociception in opiate tolerance and addiction? Nitric Oxide Biol Chem 17:55\u201359","journal-title":"Nitric Oxide Biol Chem"},{"key":"443_CR16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pharmthera.2007.10.003","volume":"117","author":"T Koch","year":"2008","unstructured":"Koch T, H\u00f6llt V (2008) Role of receptor internalization in opioid tolerance and dependence. Pharmacol Ther 117:199\u2013206","journal-title":"Pharmacol Ther"},{"key":"443_CR17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0014-2999(92)90732-J","volume":"221","author":"YA Kolesnikov","year":"1992","unstructured":"Kolesnikov YA, Pick CG, Pasternak GW (1992) NG-nitro-l-arginine prevents morphine tolerance. Eur J Pharmacol 221:399\u2013400","journal-title":"Eur J Pharmacol"},{"key":"443_CR18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0306-3623(96)00416-8","volume":"29","author":"S Kumar","year":"1997","unstructured":"Kumar S, Bhargava HN (1997) Time course of the changes in central nitric oxide synthase activity following chronic treatment with morphine in the mouse: reversal by naloxone. Gen Pharmacol 29:223\u2013227","journal-title":"Gen Pharmacol"},{"key":"443_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0014-2999(95)00474-Y","volume":"285","author":"JC Leza","year":"1995","unstructured":"Leza JC, Lizasoain I, San-Martin-Clark O, Lorenzo P (1995) Morphine-induced changes in cerebral and cerebellar nitric oxide synthase activity. Eur J Pharmacol 285:95\u201398","journal-title":"Eur J Pharmacol"},{"key":"443_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-0173(01)00057-1","volume":"38","author":"JG Liu","year":"2001","unstructured":"Liu JG, Anand KJ (2001) Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence. Brain Res Rev 38:1\u201319","journal-title":"Brain Res Rev"},{"key":"443_CR21","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0022-3565(24)29197-7","volume":"299","author":"TJ Martin","year":"2001","unstructured":"Martin TJ, Eisenach JC (2001) Pharmacology of opioid and nonopioid analgesics in chronic pain states. J Pharmacol Exp Ther 299:811\u2013817","journal-title":"J Pharmacol Exp Ther"},{"key":"443_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0304-3959(93)90124-8","volume":"52","author":"ST Meller","year":"1993","unstructured":"Meller ST, Gebhart GF (1993) Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 52:127\u2013136","journal-title":"Pain"},{"key":"443_CR23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","volume":"43","author":"S Moncada","year":"1991","unstructured":"Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109\u2013142","journal-title":"Pharmacol Rev"},{"key":"443_CR24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0092-8674(94)90266-6","volume":"78","author":"C Nathan","year":"1994","unstructured":"Nathan C, Xie Q-W (1994) Nitric oxide synthases: roles, tolls and controls. Cell 78:915\u2013918","journal-title":"Cell"},{"key":"443_CR25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0893-133X(95)00084-Q","volume":"13","author":"GW Pasternak","year":"1995","unstructured":"Pasternak GW, Kolesnikov YA, Babey AM (1995) Perspectives on the N-methyl-d-aspartate\/nitric oxide cascade and opioid tolerance. Neuropsychopharmacology 13:309\u2013313","journal-title":"Neuropsychopharmacology"},{"key":"443_CR26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2999(00)00849-9","volume":"409","author":"V Raghavendra","year":"2000","unstructured":"Raghavendra V, Kulkarni SK (2000) Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur J Pharmacol 409:279\u2013289","journal-title":"Eur J Pharmacol"},{"key":"443_CR27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0165-6147(91)90526-X","volume":"12","author":"SH Synder","year":"1991","unstructured":"Synder SH, Bredt DS (1991) Nitric oxide as a neuronal messenger. Trends Pharmacol Sci 12:125\u2013128","journal-title":"Trends Pharmacol Sci"},{"key":"443_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-3565(24)29505-7","volume":"297","author":"DA Taylor","year":"2001","unstructured":"Taylor DA, Fleming WW (2001) Unifying perspectives of the mechanisms underlying the development of tolerance and physical dependence to opioids. J Pharmacol Exp Ther 297:11\u201318","journal-title":"J Pharmacol Exp Ther"},{"key":"443_CR29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/abio.2001.5575","volume":"303","author":"T Teerlink","year":"2002","unstructured":"Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA (2002) Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303:131\u2013137","journal-title":"Anal Biochem"},{"key":"443_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/geno.2000.6262","volume":"68","author":"CT Tran","year":"2000","unstructured":"Tran CT, Fox MF, Vallance P, Leiper JM (2000) Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics 68:101\u2013105","journal-title":"Genomics"},{"key":"443_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(00)01686-0","volume":"478","author":"D Tsikas","year":"2000","unstructured":"Tsikas D, Boger RH, Sandmann J, Bode-Boger SM, Frolich JC (2000) Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett 478:1\u20133","journal-title":"FEBS Lett"},{"key":"443_CR32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.mehy.2009.02.013","volume":"73","author":"A Ulugol","year":"2009","unstructured":"Ulugol A (2009) Modulatory role of symmetric dimethylarginine (ADMA) in cannabinoid tolerance and dependence. Med Hypotheses 73:213\u2013214","journal-title":"Med Hypotheses"},{"key":"443_CR33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/nrc.10026","volume":"30","author":"A Ulugol","year":"2002","unstructured":"Ulugol A, Aslantas A, Karadag HC, Bulbul ED, Tuncer A, Dokmeci I (2002) The effect of combined systemic administration of morphine and l-name, a nitric oxide synthase inhibitor, on behavioral signs of neuropathic pain in rats. Neurosci Res Commun 30:143\u2013153","journal-title":"Neurosci Res Commun"},{"key":"443_CR34","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","volume":"339","author":"P Vallance","year":"1992","unstructured":"Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339:572\u2013575","journal-title":"Lancet"},{"key":"443_CR35","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1253\/circj.CJ-08-0240","volume":"72","author":"P Valtonen","year":"2008","unstructured":"Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, Viikari JSA, Heiskanen N, Vanninen E, Punnonen K, Heinonen S (2008) Serum l-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72:1879\u20131884","journal-title":"Circ J"},{"key":"443_CR36","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/978-3-642-77540-6_23","volume-title":"Opioids II","author":"EL Way","year":"1993","unstructured":"Way EL (1993) Opioid tolerance and physical dependence and their relationship. In: Herz A (ed) Opioids II. Springer, Berlin, pp 573\u2013596"},{"key":"443_CR37","first-page":"BR433","volume":"10","author":"W Zhu","year":"2004","unstructured":"Zhu W, Ma Y, Bell A (2004) Presence of morphine in rat amygdale: evidence for the 3 opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit 10:BR433\u2013BR439","journal-title":"Med Sci Monit"},{"key":"443_CR38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","volume":"16","author":"M Zimmermann","year":"1983","unstructured":"Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109\u2013110","journal-title":"Pain"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0443-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-010-0443-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-010-0443-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T10:12:55Z","timestamp":1740305575000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-010-0443-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,27]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["443"],"URL":"https:\/\/doi.org\/10.1007\/s00702-010-0443-2","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,27]]}}}